Athira Pharma Inc (ATHA)
2.60
+0.06
(+2.36%)
USD |
NASDAQ |
Jun 17, 16:00
2.56
-0.04
(-1.54%)
Pre-Market: 20:00
Athira Pharma Net Income (Quarterly): -26.34M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -26.34M |
December 31, 2023 | -27.28M |
September 30, 2023 | -32.97M |
June 30, 2023 | -29.60M |
March 31, 2023 | -27.82M |
December 31, 2022 | -30.14M |
September 30, 2022 | -20.19M |
June 30, 2022 | -24.34M |
March 31, 2022 | -20.98M |
December 31, 2021 | -16.34M |
Date | Value |
---|---|
September 30, 2021 | -15.67M |
June 30, 2021 | -13.97M |
March 31, 2021 | -8.866M |
December 31, 2020 | -7.702M |
September 30, 2020 | -8.456M |
June 30, 2020 | -1.992M |
March 31, 2020 | -1.805M |
December 31, 2019 | -0.974M |
September 30, 2019 | -1.53M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-32.97M
Minimum
Sep 2023
-0.974M
Maximum
Dec 2019
-16.68M
Average
-16.34M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
Xeris Biopharma Holdings Inc | -18.98M |
Kodiak Sciences Inc | -43.04M |
Phathom Pharmaceuticals Inc | -82.85M |
Inozyme Pharma Inc | -23.35M |
LENZ Therapeutics Inc | -16.65M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 27.69M |
EPS Diluted (Quarterly) | -0.69 |
Enterprise Value | -22.43M |
Earnings Yield | -117.3% |